Charles River Laboratories Announces First-Quarter 2021 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Charles River Laboratories (CRL) Tops Q1 EPS by 34c; Raises Outlook
May 4, 2021 7:02 AM EDTCharles River Laboratories (NYSE: CRL) reported Q1 EPS of $2.53, $0.34 better than the analyst estimate of $2.19. Revenue for the quarter came in at $824.6 million versus the consensus estimate of $798.53 million.
James C. Foster, Chairman, President and Chief Executive Officer, said, Our first-quarter performance demonstrates the... More
